U.S. Food and Drug Administration (FDA) recently accepted the Biologics License Application (BLA) for RP1 plus nivolumab in advanced melanoma for ...

Agellus will merge CompassMSP with portfolio company BlackPoint, a Seattle-based provider of cloud, security, and managed IT infrastructure services.

Fund managers in the expanding asset class are increasingly looking to stake sales to generate liquidity and buyers have been happy to answer the call.

CEO Jon Winkelried highlighted the firm’s strong 2024 performance, including successful integration of Angelo Gordon and surpassing the $30 billion fundraising target. This included $2 billion raised ...